LexaGene Holdings Inc. (CVE:LXG – Get Free Report) shares fell 19.2% on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares traded hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company’s fifty day moving average is C$0.11 and its 200 day moving average is C$0.11. The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The firm has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Featured Stories
- Five stocks we like better than LexaGene
- Using the MarketBeat Stock Split Calculator
- How Much Can You Make in Stocks in One Month?
- Learn Technical Analysis Skills to Master the Stock Market
- This Is the Top Large-Cap Stock Insiders Are Buying
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
